Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram in First Episode Schizophrenia
NCT01041274Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jan 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of citalopram in schizophrenia and schizophreniform disorder, sponsored by NYU Langone Health. Primary endpoint: Calgary Depression Scale for Schizophrenia. Started Jan 2010; status: completed.
02
Drugs
citalopram
03
Conditions
schizophreniaschizophreniform disorder
Beyond the preview
Go deeper on NCT01041274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041274.